Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.25 INR | -1.97% | -5.87% | -12.27% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 435.9 | 329 | 241 | 614.3 | 839.5 | 756 |
Enterprise Value (EV) 1 | 399.4 | 313.3 | 313.6 | 666.5 | 1,021 | 906 |
P/E ratio | 17.5 x | 7.3 x | 3.99 x | 27.9 x | 27 x | 29.6 x |
Yield | - | 1.25% | 1.71% | - | - | - |
Capitalization / Revenue | 2.64 x | 0.93 x | 0.5 x | 2.02 x | 2.17 x | 1.79 x |
EV / Revenue | 2.42 x | 0.88 x | 0.66 x | 2.19 x | 2.64 x | 2.14 x |
EV / EBITDA | 11.9 x | 5.06 x | 3.64 x | 20 x | 19.7 x | 16.6 x |
EV / FCF | -11.5 x | -25.9 x | -4.33 x | -82.5 x | -7.33 x | 22.3 x |
FCF Yield | -8.7% | -3.86% | -23.1% | -1.21% | -13.7% | 4.49% |
Price to Book | 2.44 x | 1.51 x | 0.86 x | 2.05 x | 2.36 x | 1.89 x |
Nbr of stocks (in thousands) | 10,281 | 10,281 | 10,281 | 10,281 | 10,281 | 10,847 |
Reference price 2 | 42.40 | 32.00 | 23.44 | 59.75 | 81.65 | 69.70 |
Announcement Date | 25/08/18 | 03/09/19 | 21/08/20 | 06/09/21 | 28/09/22 | 03/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 165.3 | 354.2 | 478.7 | 304.6 | 387.5 | 423.5 |
EBITDA 1 | 33.52 | 61.88 | 86.2 | 33.35 | 51.93 | 54.74 |
EBIT 1 | 31.6 | 58.7 | 81.54 | 28.08 | 46.31 | 45.59 |
Operating Margin | 19.11% | 16.57% | 17.03% | 9.22% | 11.95% | 10.76% |
Earnings before Tax (EBT) 1 | 25.74 | 56.66 | 76.28 | 18.68 | 33.09 | 36.24 |
Net income 1 | 18.91 | 45.05 | 60.46 | 22.05 | 31.08 | 25.39 |
Net margin | 11.44% | 12.72% | 12.63% | 7.24% | 8.02% | 6% |
EPS 2 | 2.420 | 4.382 | 5.880 | 2.140 | 3.020 | 2.351 |
Free Cash Flow 1 | -34.75 | -12.1 | -72.48 | -8.08 | -139.4 | 40.66 |
FCF margin | -21.02% | -3.41% | -15.14% | -2.65% | -35.97% | 9.6% |
FCF Conversion (EBITDA) | - | - | - | - | - | 74.29% |
FCF Conversion (Net income) | - | - | - | - | - | 160.17% |
Dividend per Share | - | 0.4000 | 0.4000 | - | - | - |
Announcement Date | 25/08/18 | 03/09/19 | 21/08/20 | 06/09/21 | 28/09/22 | 03/09/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 72.6 | 52.2 | 182 | 150 |
Net Cash position 1 | 36.5 | 15.7 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.8423 x | 1.564 x | 3.5 x | 2.741 x |
Free Cash Flow 1 | -34.8 | -12.1 | -72.5 | -8.08 | -139 | 40.7 |
ROE (net income / shareholders' equity) | 17.4% | 22.7% | 24.3% | 7.6% | 9.2% | 6.54% |
ROA (Net income/ Total Assets) | 11.3% | 14.1% | 13.6% | 3.77% | 5.24% | 4.41% |
Assets 1 | 166.6 | 319.5 | 445.2 | 585 | 592.8 | 575.9 |
Book Value Per Share 2 | 17.40 | 21.30 | 27.10 | 29.20 | 34.60 | 37.00 |
Cash Flow per Share 2 | 7.710 | 3.610 | 4.210 | 1.770 | 0.2900 | 0.7800 |
Capex 1 | 3.08 | 16.7 | 14.1 | 5.09 | 31.6 | 64.1 |
Capex / Sales | 1.87% | 4.72% | 2.94% | 1.67% | 8.16% | 15.14% |
Announcement Date | 25/08/18 | 03/09/19 | 21/08/20 | 06/09/21 | 28/09/22 | 03/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-12.27% | 1.2Cr | |
+10.08% | 4.24TCr | |
-6.13% | 1.18TCr | |
+17.70% | 584.51Cr | |
+3.72% | 412.98Cr | |
-7.06% | 225.19Cr | |
+13.91% | 222.24Cr | |
-0.20% | 162.56Cr | |
-6.25% | 143.15Cr | |
+2.11% | 142.21Cr |
- Stock Market
- Equities
- BANKA Stock
- Financials Banka BioLoo Limited